Practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen levels

Urology. 2014 Jun;83(6):1339-43. doi: 10.1016/j.urology.2014.02.014. Epub 2014 Apr 13.

Abstract

Objective: To investigate the practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen (PSA).

Materials and methods: Data were collected from general health screenings conducted at 4 university hospitals between 2004 and 2012. Eligibility criteria were Korean men aged≤40 years who were seen by urologists for high PSA (>2.5 ng/mL). After excluding individuals with chronic prostatitis and any infectious symptoms and/or signs, the practice patterns of urologists managing 237 eligible men were analyzed.

Results: The most common practice was observation after antibiotics (40.5%), followed by reassurance (38.4%), prostate biopsy (PBx) after antibiotics (11.8%), PBx after PSA follow-up (7.6%), and immediate PBx (1.7%). Antibiotics were prescribed empirically to 124 patients (52.3%). Of the entire patients, 145 of 237 (61.2%) had at least 1 follow-up PSA, and the follow-up PSA with median interval of 43 days (interquartile range, 26-149) was higher than initial PSA in 66 of 145 (45.5%). Of the 98 patients undergoing follow-up PSA after initial antibiotic treatment, 53 (54.1%) experienced a decline in PSA, whereas 45 (45.9%) experienced a rise in PSA. PBx was performed in 50 of 237 (21.1%), and only a single case (2%) of prostate cancer was diagnosed.

Conclusion: In managing men≤40 years with high PSA, the most common practice pattern was observation after antibiotic treatment despite lack of evidences. Furthermore, 1 in 5 urologists performed PBx to rule out cancer. Given the very low prevalence of cancer in this age group, clear guidelines are needed for appropriate management and consistency of care.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Biomarkers, Tumor / blood
  • Biopsy, Needle
  • Cohort Studies
  • Early Detection of Cancer / statistics & numerical data*
  • Humans
  • Immunohistochemistry
  • Male
  • Monitoring, Physiologic / methods
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Prognosis
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / drug therapy
  • Prostatitis / diagnosis*
  • Prostatitis / pathology
  • Republic of Korea
  • Retrospective Studies
  • Risk Assessment
  • Urology / standards
  • Urology / trends
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Biomarkers, Tumor
  • Prostate-Specific Antigen